Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0050863,GO:0050863,regulation of T cell activation,16/76,342/18800,4.08817685918214e-13,4.97326748472211e-10,2.90183927559874e-10,B2M/CD27/CD274/CD80/HAVCR2/HLA-E/IL15/IL6/LAG3/LGALS9/LILRB4/SIRPB1/TGFBR2/TNFRSF1B/VCAM1/VSIG4,16
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,14/76,233/18800,4.74718013329393e-13,4.97326748472211e-10,2.90183927559874e-10,CD274/CD80/CSF1/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/TGFBR2/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,14
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,15/76,291/18800,5.95838756156802e-13,4.97326748472211e-10,2.90183927559874e-10,B2M/CD27/CD274/CD80/FSTL3/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/PLAUR/SIRPB1/TGFBR2/VCAM1,15
GO:0042098,GO:0042098,T cell proliferation,13/76,204/18800,1.65112390301556e-12,8.26882850630192e-10,4.82475784712757e-10,CD274/CD80/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/TGFBR2/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,13
GO:0042129,GO:0042129,regulation of T cell proliferation,12/76,174/18800,5.0037126749026696e-12,1.60293928915074e-09,9.35294994678506e-10,CD274/CD80/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/TGFBR2/TNFRSF1B/VCAM1/VSIG4,12
GO:0050870,GO:0050870,positive regulation of T cell activation,13/76,223/18800,5.121211786424099e-12,1.60293928915074e-09,9.35294994678506e-10,B2M/CD27/CD274/CD80/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/SIRPB1/TGFBR2/VCAM1,13
GO:0032943,GO:0032943,mononuclear cell proliferation,14/76,300/18800,1.4514733666108899e-11,3.0287410916613903e-09,1.7672324849613303e-09,CD274/CD80/CSF1/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/TGFBR2/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,14
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,15/76,381/18800,2.8062831243279796e-11,4.684621962211511e-09,2.73341822916999e-09,B2M/CD27/CD274/CD80/HAVCR2/HLA-E/IL15/IL6/LAG3/LGALS9/LILRB4/SIRPB1/TGFBR2/VCAM1/VSIG4,15
GO:1903131,GO:1903131,mononuclear cell differentiation,15/76,433/18800,1.68434299975265e-10,2.3288634369573e-08,1.35886264103613e-08,B2M/CD27/CD79B/CD80/CSF1/DLL1/IL15/IL6/LAG3/LGALS9/LILRB4/LTBR/SLAMF8/TGFBR2/VCAM1,15
GO:0051251,GO:0051251,positive regulation of lymphocyte activation,14/76,371/18800,2.41574569985297e-10,3.02451361621592e-08,1.76476580599785e-08,B2M/CD27/CD274/CD80/HAVCR2/HLA-E/IL15/IL6/LGALS9/LILRB4/SIRPB1/TGFBR2/TNFRSF4/VCAM1,14
GO:0002507,GO:0002507,tolerance induction,6/76,31/18800,2.42523735498051e-09,2.42911773474848e-07,1.41735976787914e-07,CD274/HAVCR2/HLA-E/LGALS9/LILRB4/TGFBR2,6
GO:0002697,GO:0002697,regulation of immune effector process,12/76,353/18800,1.68167658711189e-08,1.55959932375117e-06,9.10006667801677e-07,B2M/CD80/HAVCR2/HLA-E/IL6/LAG3/LGALS9/LILRB4/SLAMF8/TNFRSF1B/TNFRSF4/VSIG4,12
GO:1903706,GO:1903706,regulation of hemopoiesis,12/76,371/18800,2.91130296363026e-08,2.60353665033221e-06,1.51913102011985e-06,B2M/CD27/CD80/CSF1/DLL1/FSTL3/IL15/LAG3/LGALS9/LILRB4/SLAMF8/TGFBR2,12
GO:0002274,GO:0002274,myeloid leukocyte activation,10/76,232/18800,3.15967732628276e-08,2.72821793965932e-06,1.59188099051923e-06,CSF1/HAVCR2/IFNGR1/IL15/IL6/LGALS9/LILRB4/LTBR/TGFBR2/VSIG4,10
GO:0002237,GO:0002237,response to molecule of bacterial origin,11/76,354/18800,1.73438375389838e-07,1.40093449024566e-05,8.17427725097096e-06,ADM/B2M/CD274/CD80/HAVCR2/IL18BP/IL6/LGALS9/TNFRSF11A/TNFRSF1B/VCAM1,11
GO:0046631,GO:0046631,alpha-beta T cell activation,8/76,158/18800,2.42050535397704e-07,1.83665012313894e-05,1.07166233853912e-05,CD274/CD80/HLA-E/IL15/IL6/LGALS9/LILRB4/TGFBR2,8
GO:0002822,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8/76,173/18800,4.84055734157431e-07,3.4630730238006e-05,2.02065972634741e-05,B2M/CD274/CD80/HAVCR2/HLA-E/IL6/LILRB4/TNFRSF1B,8
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,12/76,486/18800,5.37871591355083e-07,3.64008233717062e-05,2.12394244324568e-05,CSF1/EDA2R/IFNGR1/IL15/IL6/LILRB4/TNFRSF11A/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/YAP1,12
GO:0043410,GO:0043410,positive regulation of MAPK cascade,12/76,491/18800,5.99376568637734e-07,3.84830494325355e-05,2.24543772542287e-05,CD27/EDA2R/EFNA1/FGF23/GDF15/HAVCR2/IGFBP4/IL6/LGALS9/LTBR/TNFRSF11A/TNFRSF19,12
GO:0007565,GO:0007565,female pregnancy,8/76,185/18800,8.04982920649701e-07,4.79923150787346e-05,2.80029146331275e-05,ADM/BSG/HAVCR2/LGALS9/PGF/STC2/TGFBR2/TIMP1,8
GO:0001818,GO:0001818,negative regulation of cytokine production,10/76,363/18800,1.95853960045665e-06,9.43112146066047e-05,5.50294122557455e-05,CD274/DLL1/EPHA2/HAVCR2/IL6/INHBB/LAG3/LGALS9/LILRB4/VSIG4,10
GO:0046718,GO:0046718,viral entry into host cell,7/76,146/18800,2.06038920696242e-06,9.66999599628106e-05,5.64232152465029e-05,BSG/CD80/EPHA2/LGALS9/SCARB2/SIGLEC1/TNFRSF4,7
GO:0044706,GO:0044706,multi-multicellular organism process,8/76,213/18800,2.3179395677354e-06,0.0001038906433421,6.06188889183504e-05,ADM/BSG/HAVCR2/LGALS9/PGF/STC2/TGFBR2/TIMP1,8
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,10/76,370/18800,2.32343291819614e-06,0.0001038906433421,6.06188889183504e-05,B2M/CD27/CD274/CD80/HAVCR2/HLA-E/IL18BP/IL6/LILRB4/TNFRSF1B,10
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,7/76,161/18800,3.94737804358695e-06,0.0001551947011933,9.05541639719254e-05,CD274/CD80/HAVCR2/LAG3/LGALS9/LILRB4/VSIG4,7
GO:0060326,GO:0060326,cell chemotaxis,9/76,315/18800,4.94079334119881e-06,0.0001771646392668,0.0001033733476132,BSG/CSF1/EPHA2/IL6/LGALS9/PGF/SLAMF8/TNFRSF11A/VCAM1,9
GO:0032613,GO:0032613,interleukin-10 production,5/76,63/18800,5.53059550122048e-06,0.0001871433937169,0.0001091958258277,CD274/DLL1/IL6/LGALS9/LILRB4,5
GO:0032623,GO:0032623,interleukin-2 production,5/76,63/18800,5.53059550122048e-06,0.0001871433937169,0.0001091958258277,CD80/HAVCR2/LAG3/LILRB4/VSIG4,5
GO:0001503,GO:0001503,ossification,10/76,420/18800,7.12917415689217e-06,0.0002348875274849,0.0001370539297751,ATRAID/CRIM1/CSF1/EPHA2/FGF23/FSTL3/IL6/PHOSPHO1/TNFRSF11A/YAP1,10
GO:0034612,GO:0034612,response to tumor necrosis factor,8/76,249/18800,7.33971922278628e-06,0.0002364841083432,0.000137985514705,EDA2R/IL18BP/TNFRSF11A/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/VCAM1,8
GO:0042060,GO:0042060,wound healing,10/76,429/18800,8.58049250054445e-06,0.0002682584539412,0.0001565254473139,ACVRL1/F10/IL6/OCLN/PLAUR/PROS1/SDC1/TGFBR2/TIMP1/YAP1,10
GO:0045765,GO:0045765,regulation of angiogenesis,9/76,345/18800,1.02735813812109e-05,0.0003107576580011,0.0001813232004816,ACVRL1/ADM/DLL1/EFNA1/EPHA2/HSPB6/IL6/PGF/TGFBR2,9
GO:0070232,GO:0070232,regulation of T cell apoptotic process,4/76,34/18800,1.04301668538025e-05,0.0003107576580011,0.0001813232004816,CD27/CD274/EFNA1/LGALS9,4
GO:0032103,GO:0032103,positive regulation of response to external stimulus,10/76,442/18800,1.11255522548e-05,0.000323934684256,0.0001890118302284,CSF1/HAVCR2/HLA-E/IL15/IL6/LAG3/LGALS9/PGF/TNFRSF11A/TNFRSF1A,10
GO:0045824,GO:0045824,negative regulation of innate immune response,5/76,73/18800,1.1452874621011e-05,0.0003296321615058,0.0001923362368295,HAVCR2/HLA-E/LGALS9/SLAMF8/VSIG4,5
GO:0002449,GO:0002449,lymphocyte mediated immunity,9/76,365/18800,1.60869827178067e-05,0.0004190187841543,0.0002444922113697,B2M/CD27/HAVCR2/HLA-E/IL6/LAG3/LGALS9/LILRB4/TNFRSF1B,9
GO:0002369,GO:0002369,T cell cytokine production,4/76,38/18800,1.63992974629104e-05,0.0004190187841543,0.0002444922113697,B2M/IL6/LILRB4/TNFRSF1B,4
GO:0002724,GO:0002724,regulation of T cell cytokine production,4/76,38/18800,1.63992974629104e-05,0.0004190187841543,0.0002444922113697,B2M/IL6/LILRB4/TNFRSF1B,4
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,5/76,85/18800,2.40854295349244e-05,0.0005971278767866,0.0003484166356902,B2M/HAVCR2/HLA-E/LAG3/LGALS9,5
GO:0002709,GO:0002709,regulation of T cell mediated immunity,5/76,88/18800,2.84961214481874e-05,0.000679564648631,0.0003965174593492,B2M/HLA-E/IL6/LILRB4/TNFRSF1B,5
GO:0071496,GO:0071496,cellular response to external stimulus,8/76,309/18800,3.47839328349884e-05,0.0008140090450356,0.0004749640804226,DSC2/FGF23/IL15/INHBB/LTBR/TNFRSF10A/TNFRSF1A/VCAM1,8
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,4/76,46/18800,3.53778770693545e-05,0.0008202426313117,0.0004786012999246,HAVCR2/HLA-E/LAG3/LGALS9,4
GO:0032924,GO:0032924,activin receptor signaling pathway,4/76,47/18800,3.85507706327907e-05,0.0008856066941697,0.0005167404117654,ACVRL1/FSTL3/INHBB/TGFBR2,4
GO:0010862,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,4/76,49/18800,4.55144534401008e-05,0.0010014361879857,0.0005843254703733,ACVRL1/GDF15/INHBB/TGFBR2,4
GO:0002477,GO:0002477,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,2/76,3/18800,4.82572151455921e-05,0.0010014361879857,0.0005843254703733,B2M/HLA-E,2
GO:0014028,GO:0014028,notochord formation,2/76,3/18800,4.82572151455921e-05,0.0010014361879857,0.0005843254703733,EFNA1/EPHA2,2
GO:0070231,GO:0070231,T cell apoptotic process,4/76,50/18800,4.93212133741682e-05,0.0010014361879857,0.0005843254703733,CD27/CD274/EFNA1/LGALS9,4
GO:0001946,GO:0001946,lymphangiogenesis,3/76,18/18800,4.95918879034452e-05,0.0010014361879857,0.0005843254703733,ACVRL1/CLEC14A/EPHA2,3
GO:0030903,GO:0030903,notochord development,3/76,18/18800,4.95918879034452e-05,0.0010014361879857,0.0005843254703733,EFNA1/EPHA2/YAP1,3
GO:0007568,GO:0007568,aging,6/76,163/18800,5.1304317278985e-05,0.0010277280837326,0.0005996664621745,ADM/IL15/TGFBR2/TIMP1/TNFRSF1B/VCAM1,6
GO:0031341,GO:0031341,regulation of cell killing,5/76,100/18800,5.27387095909064e-05,0.0010398246363435,0.0006067246490856,B2M/HAVCR2/HLA-E/LAG3/LGALS9,5
GO:0006898,GO:0006898,receptor-mediated endocytosis,7/76,246/18800,6.11630227019919e-05,0.0011515203672615,0.0006718977088275,ADM/B2M/DLL1/LILRB4/SCARB2/SIGLEC1/TGFBR2,7
GO:0050830,GO:0050830,defense response to Gram-positive bacterium,5/76,104/18800,6.36158993942433e-05,0.0011887627767401,0.0006936281882106,EPHA2/HAVCR2/HLA-E/IL6/RNASE6,5
GO:0048771,GO:0048771,tissue remodeling,6/76,174/18800,7.37380812168937e-05,0.0013283464414899,0.0007750735079821,ACVRL1/EPHA2/IL15/IL6/TIMP1/TNFRSF11A,6
GO:0031667,GO:0031667,response to nutrient levels,9/76,446/18800,7.65881969420673e-05,0.0013601194690988,0.0007936126715609,ADM/DSC2/FGF23/GDF15/IL15/INHBB/STC2/TGFBR2/VCAM1,9
GO:0002831,GO:0002831,regulation of response to biotic stimulus,8/76,351/18800,8.51395519159246e-05,0.0014702719861894,0.0008578852853669,CD274/HAVCR2/HLA-E/IL15/LAG3/LGALS9/SLAMF8/VSIG4,8
GO:0050777,GO:0050777,negative regulation of immune response,6/76,179/18800,8.62319721975804e-05,0.0014774151009151,0.0008620532033252,HAVCR2/HLA-E/LGALS9/LILRB4/SLAMF8/VSIG4,6
GO:0002456,GO:0002456,T cell mediated immunity,5/76,112/18800,9.05018687841176e-05,0.0015209173116471,0.0008874361983211,B2M/HLA-E/IL6/LILRB4/TNFRSF1B,5
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,2/76,4/18800,9.62612117459057e-05,0.0015633194151289,0.0009121772945178,TNFRSF1A/TNFRSF1B,2
GO:0031348,GO:0031348,negative regulation of defense response,7/76,268/18800,0.0001045455907743,0.0016563642608332,0.0009664677963832,HAVCR2/HLA-E/LGALS9/SLAMF8/TNFRSF1A/TNFRSF1B/VSIG4,7
GO:0002040,GO:0002040,sprouting angiogenesis,6/76,186/18800,0.0001064994592628,0.0016563642608332,0.0009664677963832,ACVRL1/CLEC14A/DLL1/EPHA2/EPHB4/PGF,6
GO:1902993,GO:1902993,positive regulation of amyloid precursor protein catabolic process,3/76,25/18800,0.0001369636037778,0.0020046584376674,0.0011696930853717,EFNA1/IFNGR1/SPON1,3
GO:0003170,GO:0003170,heart valve development,4/76,65/18800,0.0001385007626663,0.0020046584376674,0.0011696930853717,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:0031100,GO:0031100,animal organ regeneration,4/76,65/18800,0.0001385007626663,0.0020046584376674,0.0011696930853717,ADM/IL6/PGF/TGFBR2,4
GO:0002688,GO:0002688,regulation of leukocyte chemotaxis,5/76,124/18800,0.0001462802302246,0.0020912224363105,0.0012202020941646,CSF1/IL6/LGALS9/PGF/SLAMF8,5
GO:0050900,GO:0050900,leukocyte migration,8/76,384/18800,0.0001581734248359,0.0022126606468664,0.0012910597687282,BSG/CSF1/IL6/LGALS9/PGF/SLAMF8/TNFRSF11A/VCAM1,8
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/76,5/18800,0.0001600145510628,0.002213681966085,0.0012916556956978,TNFRSF1A/TNFRSF1B,2
GO:0031349,GO:0031349,positive regulation of defense response,7/76,289/18800,0.0001666809223862,0.0022807050800826,0.0013307628430951,HAVCR2/HLA-E/IL15/IL6/LAG3/TNFRSF11A/TNFRSF1A,7
GO:0042476,GO:0042476,odontogenesis,5/76,130/18800,0.0001825084835899,0.00245699592962,0.0014336263453475,ADM/BSG/CSF1/RELT/SDC1,5
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,5/76,131/18800,0.0001891572370357,0.0025194134124342,0.0014700461646454,B2M/HAVCR2/HLA-E/LAG3/LGALS9,5
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,4/76,72/18800,0.0002060090268027,0.0027149821216527,0.0015841580565217,HAVCR2/HLA-E/LAG3/LGALS9,4
GO:0150076,GO:0150076,neuroinflammatory response,4/76,73/18800,0.0002172876443205,0.0028337930280132,0.0016534827320003,IFNGR1/IL6/MMP3/TNFRSF1B,4
GO:0045667,GO:0045667,regulation of osteoblast differentiation,5/76,136/18800,0.0002252189111289,0.002922011157859,0.0017049569056281,ATRAID/CRIM1/FGF23/IL6/YAP1,5
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,6/76,221/18800,0.0002715897186192,0.0034003032771125,0.0019840343654919,CD27/LTBR/TNFRSF10A/TNFRSF1A/TNFRSF1B/YAP1,6
GO:0001570,GO:0001570,vasculogenesis,4/76,80/18800,0.0003090681120041,0.0037751539144313,0.0022027550164918,ADM/EPHA2/TGFBR2/YAP1,4
GO:0052548,GO:0052548,regulation of endopeptidase activity,8/76,426/18800,0.0003192418694061,0.0038247925406359,0.0022317185330429,CD27/CRIM1/EFNA1/LGALS9/PLAUR/PROS1/TIMP1/WFDC2,8
GO:0032102,GO:0032102,negative regulation of response to external stimulus,8/76,429/18800,0.0003345828974176,0.0039518659204418,0.0023058642582702,HAVCR2/HLA-E/LGALS9/PROS1/SLAMF8/TNFRSF1A/TNFRSF1B/VSIG4,8
GO:0060562,GO:0060562,epithelial tube morphogenesis,7/76,328/18800,0.0003599029791814,0.0041722086105107,0.002434431457621,ACVRL1/ADM/CSF1/DLL1/EPHA2/TGFBR2/YAP1,7
GO:0033280,GO:0033280,response to vitamin D,3/76,35/18800,0.0003785913891613,0.0043686305919818,0.0025490412231674,FGF23/IL15/STC2,3
GO:0042113,GO:0042113,B cell activation,7/76,336/18800,0.0004158841562719,0.0047335178513862,0.0027619483679687,CD27/CD79B/DLL1/IL6/SLAMF8/TNFRSF4/VCAM1,7
GO:0045861,GO:0045861,negative regulation of proteolysis,7/76,350/18800,0.0005304921052946,0.0058261062792014,0.0033994600283889,CD27/CRIM1/EFNA1/PLAUR/PROS1/TIMP1/WFDC2,7
GO:0003007,GO:0003007,heart morphogenesis,6/76,254/18800,0.0005687302278326,0.0061106222712799,0.0035654715455425,ACVRL1/DLL1/EFNA1/EPHB4/TGFBR2/YAP1,6
GO:0014002,GO:0014002,astrocyte development,3/76,43/18800,0.0006974816539754,0.0071872183603063,0.0041936518766206,DLL1/IFNGR1/IL6,3
GO:0002291,GO:0002291,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/76,10/18800,0.0007106798085974,0.0072201094369158,0.0042128434077851,HAVCR2/LGALS9,2
GO:0043534,GO:0043534,blood vessel endothelial cell migration,5/76,175/18800,0.0007150907110044,0.0072201094369158,0.0042128434077851,ACVRL1/CLEC14A/EFNA1/EPHA2/EPHB4,5
GO:0001894,GO:0001894,tissue homeostasis,6/76,272/18800,0.0008132373413739,0.0079567758033002,0.0046426790041116,B2M/CSF1/IL6/OCLN/TNFRSF11A/YAP1,6
GO:1901652,GO:1901652,response to peptide,8/76,491/18800,0.0008134722865993,0.0079567758033002,0.0046426790041116,ADM/BSG/GDF15/INHBB/MMP3/STC2/TIMP1/VCAM1,8
GO:0070741,GO:0070741,response to interleukin-6,3/76,46/18800,0.0008505072728047,0.0082866545179107,0.004835159101589,FGF23/IL6/YAP1,3
GO:0040015,GO:0040015,negative regulation of multicellular organism growth,2/76,11/18800,0.0008663343711215,0.0083434664049553,0.0048683081259786,GDF15/STC2,2
GO:0071492,GO:0071492,cellular response to UV-A,2/76,11/18800,0.0008663343711215,0.0083434664049553,0.0048683081259786,MMP3/TIMP1,2
GO:0001906,GO:0001906,cell killing,5/76,185/18800,0.0009179597237704,0.0086412449185012,0.0050420581582645,B2M/HAVCR2/HLA-E/LAG3/LGALS9,5
GO:0031099,GO:0031099,regeneration,5/76,188/18800,0.0009864282400703,0.0091822167774574,0.0053577084610353,ADM/IL6/PGF/TGFBR2/YAP1,5
GO:0001666,GO:0001666,response to hypoxia,6/76,286/18800,0.0010541285787023,0.0096333502228855,0.0056209391749475,ACVRL1/ADM/PGF/STC2/TGFBR2/VCAM1,6
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,3/76,50/18800,0.0010855010741802,0.0098481691657509,0.0057462833370028,ACVRL1/DLL1/YAP1,3
GO:1903053,GO:1903053,regulation of extracellular matrix organization,3/76,50/18800,0.0010855010741802,0.0098481691657509,0.0057462833370028,IL6/TNFRSF1A/TNFRSF1B,3
GO:0002526,GO:0002526,acute inflammatory response,4/76,113/18800,0.0011379876748443,0.0102870799198929,0.006002382263667,HLA-E/IL6/TNFRSF11A/VCAM1,4
GO:0048013,GO:0048013,ephrin receptor signaling pathway,3/76,52/18800,0.0012168908866125,0.0107006345557194,0.0062436862129387,EFNA1/EPHA2/EPHB4,3
GO:0001763,GO:0001763,morphogenesis of a branching structure,5/76,199/18800,0.0012703505404041,0.0109688198385241,0.0064001689658111,ADM/CSF1/EPHA2/TGFBR2/YAP1,5
GO:0030278,GO:0030278,regulation of ossification,4/76,118/18800,0.0013358297461682,0.0113003975824503,0.0065936404256099,ATRAID/CSF1/FGF23/PHOSPHO1,4
GO:0002064,GO:0002064,epithelial cell development,5/76,203/18800,0.0013872467420156,0.0116958445858825,0.0068243787982196,DLL1/EPHA2/SDC1/TNFRSF1A/YAP1,5
GO:0070141,GO:0070141,response to UV-A,2/76,14/18800,0.0014221664248264,0.0117141602887021,0.0068350657813681,MMP3/TIMP1,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/76,14/18800,0.0014221664248264,0.0117141602887021,0.0068350657813681,TNFRSF1A/TNFRSF1B,2
GO:0034205,GO:0034205,amyloid-beta formation,3/76,56/18800,0.0015087781580504,0.0123061254324374,0.0071804700269981,EFNA1/IFNGR1/SPON1,3
GO:0002440,GO:0002440,production of molecular mediator of immune response,6/76,312/18800,0.0016433897350013,0.0131892560783444,0.0076957656956205,B2M/HLA-E/IL6/LILRB4/TNFRSF1B/TNFRSF4,6
GO:0060249,GO:0060249,anatomical structure homeostasis,6/76,319/18800,0.0018381739395801,0.0145433110160883,0.0084858397891082,B2M/CSF1/IL6/OCLN/TNFRSF11A/YAP1,6
GO:0071214,GO:0071214,cellular response to abiotic stimulus,6/76,323/18800,0.0019570839716431,0.0151719450928621,0.0088526398978024,LTBR/MMP3/TIMP1/TNFRSF10A/TNFRSF1A/YAP1,6
GO:0104004,GO:0104004,cellular response to environmental stimulus,6/76,323/18800,0.0019570839716431,0.0151719450928621,0.0088526398978024,LTBR/MMP3/TIMP1/TNFRSF10A/TNFRSF1A/YAP1,6
GO:0043030,GO:0043030,regulation of macrophage activation,3/76,62/18800,0.0020231077239623,0.0155394531926435,0.0090670762701316,HAVCR2/IL6/VSIG4,3
GO:0050673,GO:0050673,epithelial cell proliferation,7/76,443/18800,0.0020758666302226,0.0158959328503898,0.0092750776846902,ACVRL1/B2M/EPHA2/IGFBP4/IL6/PGF/YAP1,7
GO:0019885,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,2/76,17/18800,0.0021088083383536,0.0160013820582952,0.0093366059765065,B2M/HLA-E,2
GO:0050920,GO:0050920,regulation of chemotaxis,5/76,225/18800,0.0021772835984794,0.0163721265182957,0.0095529307244805,CSF1/IL6/LGALS9/PGF/SLAMF8,5
GO:0044320,GO:0044320,cellular response to leptin stimulus,2/76,18/18800,0.0023662103946598,0.0173988304124756,0.0101519995848815,FGF23/INHBB,2
GO:0048535,GO:0048535,lymph node development,2/76,18/18800,0.0023662103946598,0.0173988304124756,0.0101519995848815,IL15/TNFRSF11A,2
GO:0070555,GO:0070555,response to interleukin-1,4/76,141/18800,0.002561293786695,0.018324227548241,0.0106919572208502,IL6/INHBB/LGALS9/TNFRSF11A,4
GO:0003143,GO:0003143,embryonic heart tube morphogenesis,3/76,70/18800,0.0028613273301487,0.0199575588710098,0.011644985586414,DLL1/TGFBR2/YAP1,3
GO:0002837,GO:0002837,regulation of immune response to tumor cell,2/76,20/18800,0.0029231020781108,0.0199984907201899,0.011668868807644,CD274/HAVCR2,2
GO:0010038,GO:0010038,response to metal ion,6/76,351/18800,0.0029604666755515,0.020198933393954,0.0117858245967749,B2M/BSG/FGF23/INHBB/SDC1/VCAM1,6
GO:0033674,GO:0033674,positive regulation of kinase activity,7/76,476/18800,0.0030990263667075,0.0210868533212929,0.0123039147511159,CSF1/EFNA1/EPHA2/EPHB4/TGFBR2/TNFRSF10A/TNFRSF11A,7
GO:0031668,GO:0031668,cellular response to extracellular stimulus,5/76,245/18800,0.0031432609986311,0.0212722311907364,0.0124120804156474,DSC2/FGF23/IL15/INHBB/VCAM1,5
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,3/76,74/18800,0.0033495477256181,0.0222473939123285,0.0129810756475164,DLL1/PGF/VCAM1,3
GO:0090132,GO:0090132,epithelium migration,6/76,361/18800,0.0033989093057087,0.0225155261944303,0.0131375274751426,ACVRL1/CLEC14A/EFNA1/EPHA2/EPHB4/TGFBR2,6
GO:0044321,GO:0044321,response to leptin,2/76,22/18800,0.0035353478682795,0.0231136059064543,0.0134864994947699,FGF23/INHBB,2
GO:0046885,GO:0046885,regulation of hormone biosynthetic process,2/76,22/18800,0.0035353478682795,0.0231136059064543,0.0134864994947699,ADM/STC2,2
GO:0071305,GO:0071305,cellular response to vitamin D,2/76,22/18800,0.0035353478682795,0.0231136059064543,0.0134864994947699,FGF23/IL15,2
GO:0071216,GO:0071216,cellular response to biotic stimulus,5/76,256/18800,0.0037901729552697,0.0238177722152718,0.0138973717146449,CD274/CD80/HAVCR2/IL6/TNFRSF1B,5
GO:0046697,GO:0046697,decidualization,2/76,23/18800,0.0038619450868686,0.0238177722152718,0.0138973717146449,BSG/STC2,2
GO:0051346,GO:0051346,negative regulation of hydrolase activity,6/76,371/18800,0.0038841529679443,0.0238177722152718,0.0138973717146449,CD27/CRIM1/PLAUR/PROS1/TIMP1/WFDC2,6
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,HLA-E,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,DLL1,1
GO:0036325,GO:0036325,vascular endothelial growth factor receptor-3 signaling pathway,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,CLEC14A,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,VCAM1,1
GO:0071283,GO:0071283,cellular response to iron(III) ion,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,B2M,1
GO:0075512,GO:0075512,clathrin-dependent endocytosis of virus by host cell,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,SIGLEC1,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,CSF1,1
GO:1903771,GO:1903771,positive regulation of beta-galactosidase activity,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,PSAP,1
GO:1905572,GO:1905572,ganglioside GM1 transport to membrane,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,PSAP,1
GO:1990636,GO:1990636,reproductive senescence,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,INHBB,1
GO:2000184,GO:2000184,positive regulation of progesterone biosynthetic process,1/76,1/18800,0.0040425531914898,0.0238177722152718,0.0138973717146449,ADM,1
GO:0060284,GO:0060284,regulation of cell development,7/76,500/18800,0.0040586526563032,0.0238564935478479,0.0139199651271283,B2M/DLL1/IL6/SLAMF8/TNFRSF1A/TNFRSF1B/YAP1,7
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,2/76,24/18800,0.0042020420113537,0.0244692770275625,0.0142775166110042,TIMP1/TNFRSF1B,2
GO:0030500,GO:0030500,regulation of bone mineralization,3/76,81/18800,0.0043205346376196,0.0250430989180549,0.0146123344956533,ATRAID/FGF23/PHOSPHO1,3
GO:2000193,GO:2000193,positive regulation of fatty acid transport,2/76,25/18800,0.0045555270902733,0.0262230800782633,0.0153008387206279,FABP3/TNFRSF11A,2
GO:0035050,GO:0035050,embryonic heart tube development,3/76,84/18800,0.0047835893383905,0.0273472778614836,0.0159567940439462,DLL1/TGFBR2/YAP1,3
GO:0060561,GO:0060561,apoptotic process involved in morphogenesis,2/76,26/18800,0.0049222894327543,0.0277599386027406,0.0161975764169346,TNFRSF1A/TNFRSF1B,2
GO:0034103,GO:0034103,regulation of tissue remodeling,3/76,86/18800,0.0051083253203293,0.0287443743867518,0.0167719823645584,IL15/IL6/TNFRSF11A,3
GO:0002418,GO:0002418,immune response to tumor cell,2/76,27/18800,0.005302218805108,0.029228656527987,0.0170545549272095,CD274/HAVCR2,2
GO:0071772,GO:0071772,response to BMP,4/76,173/18800,0.0053111176997739,0.029228656527987,0.0170545549272095,ACVRL1/CRIM1/FSTL3/GDF15,4
GO:0035265,GO:0035265,organ growth,4/76,175/18800,0.0055297381605168,0.0301665890063927,0.0176018267785745,DLL1/PSAP/TGFBR2/YAP1,4
GO:0051591,GO:0051591,response to cAMP,3/76,89/18800,0.0056198436446856,0.0305914967093323,0.017849755100283,BSG/INHBB/SDC1,3
GO:0070723,GO:0070723,response to cholesterol,2/76,28/18800,0.0056952056274436,0.03093447915644,0.0180498810615179,INHBB/TGFBR2,2
GO:0002474,GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,2/76,29/18800,0.0061011409702963,0.0326507645990876,0.0190513121168377,B2M/HLA-E,2
GO:0034109,GO:0034109,homotypic cell-cell adhesion,3/76,93/18800,0.0063481617118103,0.0337490380602403,0.0196921409229921,DSC2/IL6/PLAUR,3
GO:0071295,GO:0071295,cellular response to vitamin,2/76,31/18800,0.0069514247317111,0.0362632656837598,0.0211591612447699,FGF23/IL15,2
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,3/76,97/18800,0.0071303243812658,0.0371191938683777,0.0216585846180042,IL6/LILRB4/SLAMF8,3
GO:0060485,GO:0060485,mesenchyme development,5/76,301/18800,0.007450268719621,0.0379075454199401,0.0221185778724049,ACVRL1/EFNA1/IL6/TGFBR2/YAP1,5
GO:0002384,GO:0002384,hepatic immune response,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,IL6,1
GO:0021693,GO:0021693,cerebellar Purkinje cell layer structural organization,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,DLL1,1
GO:0032605,GO:0032605,hepatocyte growth factor production,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,INHBB,1
GO:0032832,GO:0032832,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,LGALS9,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,CSF1,1
GO:0060434,GO:0060434,bronchus morphogenesis,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,TGFBR2,1
GO:0071812,GO:0071812,positive regulation of fever generation by positive regulation of prostaglandin secretion,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,TNFRSF11A,1
GO:0097102,GO:0097102,endothelial tip cell fate specification,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,DLL1,1
GO:1904432,GO:1904432,regulation of ferrous iron binding,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,B2M,1
GO:1904434,GO:1904434,positive regulation of ferrous iron binding,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,B2M,1
GO:1904435,GO:1904435,regulation of transferrin receptor binding,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,B2M,1
GO:1904437,GO:1904437,positive regulation of transferrin receptor binding,1/76,2/18800,0.008068978318222,0.0379075454199401,0.0221185778724049,B2M,1
GO:0048608,GO:0048608,reproductive structure development,6/76,433/18800,0.0081188835699832,0.0380705701483858,0.0222137007591893,ADM/BSG/INHBB/PSAP/SDC1/STC2,6
GO:0010717,GO:0010717,regulation of epithelial to mesenchymal transition,3/76,102/18800,0.0081851694869707,0.038238179842117,0.0223114989157804,EFNA1/IL6/TGFBR2,3
GO:0110149,GO:0110149,regulation of biomineralization,3/76,103/18800,0.0084065582205077,0.0391264345430322,0.0228297844063093,ATRAID/FGF23/PHOSPHO1,3
GO:0010614,GO:0010614,negative regulation of cardiac muscle hypertrophy,2/76,35/18800,0.0088026530198033,0.0403696761201238,0.0235552002920514,TNFRSF1A/TNFRSF1B,2
GO:0009612,GO:0009612,response to mechanical stimulus,4/76,201/18800,0.0089378003240056,0.0407654863593991,0.0237861506082251,LTBR/TGFBR2/TNFRSF10A/TNFRSF1A,4
GO:0006959,GO:0006959,humoral immune response,5/76,317/18800,0.0092011137731306,0.041814135912739,0.0243980244858255,HLA-E/IL6/RNASE6/VSIG4/WFDC2,5
GO:0032350,GO:0032350,regulation of hormone metabolic process,2/76,36/18800,0.0092962319164925,0.0421698636211908,0.0246055871473906,ADM/STC2,2
GO:0010876,GO:0010876,lipid localization,6/76,446/18800,0.0093158813663106,0.0421825803639092,0.0246130072074601,FABP3/GM2A/IL6/PSAP/SCARB2/TNFRSF11A,6
GO:0051090,GO:0051090,regulation of DNA-binding transcription factor activity,6/76,452/18800,0.0099090252517899,0.0444663068646632,0.0259455330116666,EDA2R/HAVCR2/IL6/LGALS9/TNFRSF11A/TNFRSF4,6
GO:0048545,GO:0048545,response to steroid hormone,5/76,330/18800,0.0108188983389076,0.0479478255586275,0.0279769555554796,ADM/IL6/SDC1/TGFBR2/YAP1,5
GO:0045446,GO:0045446,endothelial cell differentiation,3/76,117/18800,0.011878736516886,0.0488637552986746,0.0285113890846478,ACVRL1/DLL1/TNFRSF1A,3
GO:0010591,GO:0010591,regulation of lamellipodium assembly,2/76,41/18800,0.0119435726631233,0.0488637552986746,0.0285113890846478,EPHA2/OCLN,2
GO:0045124,GO:0045124,regulation of bone resorption,2/76,41/18800,0.0119435726631233,0.0488637552986746,0.0285113890846478,IL6/TNFRSF11A,2
GO:0003430,GO:0003430,growth plate cartilage chondrocyte growth,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,TGFBR2,1
GO:0010979,GO:0010979,regulation of vitamin D 24-hydroxylase activity,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,FGF23,1
GO:0010980,GO:0010980,positive regulation of vitamin D 24-hydroxylase activity,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,FGF23,1
GO:0045168,GO:0045168,cell-cell signaling involved in cell fate commitment,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,DLL1,1
GO:0046331,GO:0046331,lateral inhibition,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,DLL1,1
GO:0046882,GO:0046882,negative regulation of follicle-stimulating hormone secretion,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,INHBB,1
GO:0048320,GO:0048320,axial mesoderm formation,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,EPHA2,1
GO:0048627,GO:0048627,myoblast development,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,SDC1,1
GO:0060086,GO:0060086,circadian temperature homeostasis,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,TNFRSF11A,1
GO:0060279,GO:0060279,positive regulation of ovulation,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,INHBB,1
GO:0060400,GO:0060400,negative regulation of growth hormone receptor signaling pathway,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,GDF15,1
GO:1904017,GO:1904017,cellular response to Thyroglobulin triiodothyronine,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,INHBB,1
GO:1904098,GO:1904098,regulation of protein O-linked glycosylation,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,IL15,1
GO:1904100,GO:1904100,positive regulation of protein O-linked glycosylation,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,IL15,1
GO:1990428,GO:1990428,miRNA transport,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,TGFBR2,1
GO:2000634,GO:2000634,regulation of primary miRNA processing,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,IL6,1
GO:2000635,GO:2000635,negative regulation of primary miRNA processing,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,IL6,1
GO:2000676,GO:2000676,positive regulation of type B pancreatic cell apoptotic process,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,IL6,1
GO:2000978,GO:2000978,negative regulation of forebrain neuron differentiation,1/76,3/18800,0.0120793388697602,0.0488637552986746,0.0285113890846478,B2M,1
GO:0043500,GO:0043500,muscle adaptation,3/76,118/18800,0.0121537688674264,0.0489277126109901,0.0285487073751699,IL15/TNFRSF1A/TNFRSF1B,3
GO:1904019,GO:1904019,epithelial cell apoptotic process,3/76,118/18800,0.0121537688674264,0.0489277126109901,0.0285487073751699,IL6/TGFBR2/YAP1,3
GO:0007596,GO:0007596,blood coagulation,4/76,221/18800,0.0123330348503129,0.0495696938445965,0.0289232953826719,F10/IL6/PLAUR/PROS1,4
